TWiV 713: COVID-19 clinical update #47 with Dr. Daniel Griffin
b'
In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.
Hosts:\\xa0Daniel Griffin and Vincent Racaniello
Subscribe (free):\\xa0iTunes,\\xa0Google Podcasts,\\xa0RSS,\\xa0email
Become a\\xa0patron\\xa0of\\xa0TWiV!
Links for this episode
- Novavax vaccine phase 3 results (Novavax)
- J&J vaccine phase 3 results (J&J)
- COVID-19 and transmission in K-12 schools (MMWR)
- Lilly mAb therapy (NEJM)
- Regeneron mAb prophylaxis (Regeneron)
- Colchicine for COVID-19 (Cardiol Today)
- Letters read on TWiV 713
- Timestamps by Jolene. Thanks!
Intro music is by\\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv